Abstract
Testosterone, administered in the form of an inclusion complex with 2-hydroxypropyl-β-cyclodextrin by subcutaneous injection, enters the circulation in a manner markedly similar to the natural episodic release by the testes. The effects of a regimen of once-a-day administration of complexed testosterone to adult (castrated or intact) rats and to senescent (intact) rats were investigated. Although this procedure left the castrated animals with concentrations of circulatory hormone far below physiological levels for much of the day, a significant improvement in androgen-sensitive behavior and physiology was obtained. Furthermore, the testosterone effects were more pronounced when high doses were used periodically rather than when the same total amount of testosterone was equally divided among doses. The same supplementation to intact rats intensified androgen-sensitive behavior and physiology over normal levels. In senescent rats uniform pulses of the testosterone complex also improved behavior and physiology. Specifically, spermatogenesis was stimulated and, notably, the treatment increased muscle weight without substantial enlargement of the prostate. Since the testosterone–cyclodextrin complex also can be effectively administered as a sublingual tablet, the data suggest that similar regimens may be recommended for elderly men suffering from decreases in muscle mass.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
F. E. Yates. Biol. Reprod. 24:73 (1981).
G. B. Ellis and C. Desjardins. Endocrinology 110:1618–1627 (1982).
J. D. Veldhuis, M. L. Carlson, and M. L. Johnson. Proc. Natl. Acad. Sci. USA 84:7686–7690 (1987).
C. Desjardins. Biol. Reprod. 24:1–21 (1981).
J. M. Graham and C. Desjardins. Science 210:1039–1041 (1980).
J. Brotherton. Sex Hormone Pharmacology, Academic Press, New York, 1976.
D. P. DeKlerk, D. S. Coffey, L. L. Ewing, I. R. McDermott, W. G. Reiner, C. H. Robinson, W. W. Scott, J. D. Strandberg, P. Talalay, P. C. Walsh, L. G. Wheaton, and B. R. Zirkin. J. Clin. Invest. 64:842–849 (1979).
W. E. Berndtson, C. Desjardins, and L. L. Ewing. J. Endocrinol. 62:125–135 (1974).
G. T. Taylor, J. Weiss, and J. Haller. Anat. Rec. 211:304–310 (1985).
G. T. Taylor, J. Weiss, and T. Frechmann, J. Reprod. Fertil. 77:419–423 (1986).
K. Hirano and H. Yamada. Chem. Pharm. Bull. Jap. 29:1410–1415 (1981).
J. Pitha, S. M. Harman, and M. E. Michel. J. Pharm. Sci. 75:165–167 (1986).
T. O. Carpenter, J. M. Pettifor, R. M. Russell, J. Pitha, S. Mobarhan, M. S. Ossip, S. Wainer, and C. S. Anast. J. Pediat. 111:507–512 (1987).
G. B. Ellis and C. Desjardins. Biol. Reprod. 30:619–627 (1984).
N. B. Schwartz and S. N. Justo. Endocrinology 100:1550–1556 (1977).
L. W. Kaler and W. B. Neaves. Endocrinology 108:712–719 (1981).
A. Coquelin and C. Desjardins. Am. J. Physiol. 243:E257–E263 (1982).
C. H. Phoenix and K. C. Chambers. Proc. Soc. Exp. Biol. Med. 183:151–162 (1986).
R. A. Steiner, W. J. Bremner, D. K. Clifton, and D. M. Dorsa. Biol. Reprod. 31:251–258 (1984).
E. Nieschlag. In R. J. Santen and R. S. Swordloff (eds.), Male Reproductive Dysfunction, Marcel Dekker, New York, 1986, p. 199.
G. T. Taylor, J. Weiss, and R. Rupich. Physiol. Behav. 35:735–739 (1985).
E. C. Grant. Behavior 21:260–281 (1963).
G. T. Taylor, D. Regan, and J. Haller. J. Endocrinol. 96:143–152 (1983).
FDA. FDA Drug Bulletin, Oct. 1987, pp. 27–28.
J. D. Wilson and J. E. Griffin. Metabolism 29:1278–1295 (1980).
L. L. Ewing, C. Desjardins, and L. G. Stratton. In J. Urquhart and F. E. Yates (eds.), Temporal Aspects of Therapeutics, Plenum Press, New York, 1973, p. 165.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taylor, G.T., Weiss, J. & Pitha, J. Testosterone in a Cyclodextrin-Containing Formulation: Behavioral and Physiological Effects of Episode-like Pulses in Rats. Pharm Res 6, 641–646 (1989). https://doi.org/10.1023/A:1015922019038
Issue Date:
DOI: https://doi.org/10.1023/A:1015922019038